SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2852What is your expectation for INCY quarterly report in the next couple weeks? DoWatch_It_Drop-4/24/2013
2851I'm still quite bullish. I have high hopes for baricitinib, even though theNP1986-3/28/2013
2850Given the risk associated with Jakafi, what is your sentiment toward the stock? Watch_It_Drop-3/27/2013
2849Given that the patient was on Jakafi for 3 months before developing PML, it'NP1986-3/18/2013
2848Yup, per Brean Capital the "background rate of PML in MF patients is known fred hayes-3/18/2013
2847I'm wondering whether myelofibrosis itself has any risk of PML. Anybody havfred hayes-3/18/2013
2846>Assuming rux has no effect at all on PML, how long will it be before this caformer_pgs-3/18/2013
2845Irrespective of the outcome, it's likely to be quite some time before any junigel bates-3/18/2013
2844I have been asked to explain the potential relevance of the cns penetration of tBiotech Jim-3/18/2013
2843A reliable poster on Twitter notes that this patient was on drug for 1 month. I&former_pgs-3/18/2013
2842I actually sold the last of my trading shares on Friday, as a broken clock is coBiotech Jim-3/18/2013
2841From the EMEA filing documents regarding CNS penetration of ruxolitinib (ie, JakBiotech Jim-3/18/2013
2840Does anyone in here take this opportunity to buy more? Thanks!Watch_It_Drop-3/18/2013
2839PML rears its ugly head in a 75 yr old ruxo-treated myelofibrosis patient. DrugBiotech Jim-3/18/2013
2838I seems to me that you are a short-seller. I hope that you don't get burnedWatch_It_Drop-3/6/2013
2837Do you have something to say, or a point to make about Incyte? Or, is all you oquantman43/3/2013
2836Exercising options and selling is still selling.DewDiligence_on_SI-3/2/2013
2835Incorrect! The only one who sold actual shares he/she owned was the original fouquantman33/2/2013
2834Five INCY insiders sold an aggregate $8.5M of stock during the past couple of weDewDiligence_on_SI-3/2/2013
2833BJ, <I> Not sure what is going on </I> perhaps the cc answers besoftware salesperson-2/16/2013
2832Dagnappit. Someone tell me why I took profits yesterday on more than half of myBiotech Jim-2/15/2013
2831I have to listen to the remainder of the INCY CC. I listened to the first part Biotech Jim-2/14/2013
2830There's a gaggle of jak1-selective molecules following 110.scaram(o)uche-2/14/2013
2829Incyte Reports 2012 Fourth-Quarter and Full-Year Financial[graphic] Results; ProBiotech Jim-2/14/2013
2828Novartis now enrolling jakafi plus BKM120 trial. BKM120 is a pan-active PI3K inhscaram(o)uche12/7/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News